Mankind Pharma Limited — Others, 04-07-2025: Copy of Newspaper Publication

Mankind Pharma Limited has announced a board meeting to consider the financial results for the quarter and half-year ending March 31, 2025. The company will hold its 34th Annual General Meeting through video conferencing, where shareholders can participate and vote electronically. The Annual Report and AGM notice will be sent electronically to members with registered email addresses. Members holding shares in dematerialized form are advised to update their email and KYC details with their depositories to ensure receipt of communications. Remote e-voting and e-voting during the AGM will be facilitated through NSDL to enable shareholder participation.